Related Experiment Videos
Angiogenesis and colonization in the tumor metastatic process: basic and applied advances
1Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.
Abstract:
Tumor metastasis is a major cause of death for cancer patients. This review proposes that the final steps in the development of a distant metastasis may be the most productive targets for clinical development. It cannot be guaranteed that, in "metastasis-free" patients, tumor cells have not invaded out of the primary lesion, intravasated and extravasated from the circulatory system, and are sitting at distant sites as occult micrometastases. The remaining processes involved in outgrowth at metastatic sites, colonization and angiogenesis, are reviewed. Colonization is thought to be accomplished by clonally dominant cell populations through progressive independence from exogenous growth factors, production of growth factors, and stimulatory proliferative responses to traditionally inhibitory cytokines. Therapeutic efforts aimed at interrupting the switch in tumor cell responsiveness to cytokines, rather than to any one specific cytokine, may be most successful at inhibiting metastatic colonization. Angiogenesis has been demonstrated to be directly or indirectly induced by a plethora of cytokines. Partial suppression of neovascularization can be achieved in tissue culture and animal models using various natural and pharmaceutical angiostatic agents. However, as with clonal dominance, such agents must be able to suppress the redundant effects of angiogenesis-promoting factors. This review discusses the current literature on colonization and angiogenesis, emphasizing its underlying mechanisms and potential therapeutic applications.
Insights
Targeting the final steps of tumor metastasis, such as colonization and angiogenesis, offers promising clinical development opportunities. Understanding these processes is key to inhibiting cancer spread and improving patient survival.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Tumor metastasis is a primary cause of cancer-related mortality.
- Early metastatic events may occur undetected, forming occult micrometastases.
- The review focuses on the later stages of metastasis: colonization and angiogenesis.
Purpose of the Study:
- To review the mechanisms of tumor cell colonization and angiogenesis in distant metastatic sites.
- To identify potential therapeutic targets within these late-stage metastatic processes.
- To discuss the clinical implications of targeting colonization and angiogenesis.
Main Methods:
- Literature review of current research on tumor metastasis, focusing on colonization and angiogenesis.
- Analysis of mechanisms underlying clonal dominance and cytokine responsiveness in colonization.
- Examination of factors and agents involved in angiogenesis and neovascularization.
Main Results:
- Colonization involves the development of growth factor independence and altered cytokine responses.
- Therapeutic strategies targeting cytokine responsiveness may inhibit metastatic colonization.
- Angiogenesis is regulated by numerous cytokines, and effective angiostatic agents must overcome redundant pathways.
Conclusions:
- The final steps of metastasis, colonization and angiogenesis, represent critical and potentially targetable phases for clinical intervention.
- Developing therapies that disrupt tumor cell adaptation to microenvironments and promote neovascularization is crucial.
- Further research into the mechanisms of colonization and angiogenesis can lead to novel anti-metastatic treatments.